Medicare Part B

  • Medicare Drug Claims Met a Code Check With No Guard at the Door

    Medicare claims can encounter many checks on their way through the system. One relevant check, it turns out, was missing: a system edit to verify that the procedure code billed alongside a drug matched the codes associated with that drug in CMS crosswalk files. The HHS Office of Inspector General has now put that gap on paper, where it sits with the stillness of a form that knows it has been noticed.

    OIG reviewed Medicare Part B outpatient drug claims from April 1, 2024, through March 31, 2025. It identified 160,918 claim lines with procedure-code and drug-code mismatches when compared with the CMS crosswalk files. A mismatch is a flag for review, not proof that a provider used the wrong code or that Medicare paid incorrectly. The crosswalk is a reference; the finding says the codes did not line up with it.

    Medicare paid $27.6 million for those claim lines. That figure needs its own guardrail: OIG did not determine whether the mismatches caused overpayments or underpayments across the 160,918 lines. So this is not a report establishing $27.6 million in losses, recoverable money, or improper payments. It is the amount paid on claims that met the report’s mismatch criteria. The number is large; the conclusion is narrower.

    OIG also examined a nonstatistical sample of 30 claim lines. In that sample, it found incorrect procedure codes on 24 lines. Eleven of those 24 were paid under a system in which the errors could have resulted in improper payments. Those are sample findings, not a projection about all 160,918 lines. The sample shows why the mismatch deserved scrutiny; it does not calculate the overall financial effect.

    The report identifies two control weaknesses. CMS and its contractors lacked system edits to check the relevant code matches, and provider education did not specifically address those mismatches. In bureaucratic terms, the paperwork could identify a pairing worth checking, but the routine gate did not perform that check—and the guidance did not put the issue plainly in front of providers. The filing coughed; the controls remained seated.

    For patients and taxpayers, the useful takeaway is not that every flagged claim was wrong. It is that a national oversight system had an identified code-matching risk without a specific automated check or targeted education, while the report could not establish the payment impact across the full set. That distinction matters. Accountability begins with finding the missing check, then measuring what it actually allowed through—not turning a flagged total into a verdict the audit did not reach.

  • |

    Medicare Paid More Than the Bill, Because Apparently Even the Bill Needs Oversight

    I have spent the morning exhuming a HHS-OIG audit, and the document coughed. The review examined 801 selected Medicare Part B claim lines from payments made in 2022 and 2023. Among them were 138 incorrect lines that produced at least $140,182 in overpayments. Another 31 lines, totaling $76,640, lacked supporting documentation. This is not proof that every claim was improper; it is a selected sample with enough administrative thunder to make the filing cabinet nervous.

    The target here is not patients or an accusation that providers acted intentionally. The target is the payment-control machinery: the edits, reviews, and safeguards assigned to notice when Medicare money is headed somewhere it should not go. Wisconsin Physicians Service Insurance Corporation already had system edits and follow-up procedures intended to identify overpayments. HHS-OIG still found incorrect payments and unsupported claim lines in the reviewed sample, which suggests the controls were present in the same way a smoke detector is present during a very organized kitchen fire.

    Hugh Jass Serious Investigative Reporting has located the central contradiction: the claim was important enough to generate edits, reviews, and recommendations, but not important enough to stop the money first. The system had a process for checking the paperwork, a process for checking the checking, and apparently a later process for discovering that the first two processes had allowed the money to leave the building wearing sunglasses.

    HHS-OIG recommended corrective action, and WPS concurred with those recommendations. The audit does not establish a recovery outcome, so the responsible sentence ends there. That restraint is called evidence, a rare substance often found in the same room as a spreadsheet but never invited to the budget meeting.

    The invoice, in other words, survived quality control by becoming a payment. Before the money moved, the bill was suspicious. After the money moved, it appears to have received diplomatic immunity. Medicare oversight is supposed to catch mistakes; in this case, the auditors had to audit the audit trail, proving once again that paperwork is not useless. It is merely waiting for another layer of paperwork to explain why it failed.

End of content

End of content